These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Involvement of a novel organic cation transporter in verapamil transport across the inner blood-retinal barrier.
    Author: Kubo Y, Kusagawa Y, Tachikawa M, Akanuma S, Hosoya K.
    Journal: Pharm Res; 2013 Mar; 30(3):847-56. PubMed ID: 23179781.
    Abstract:
    PURPOSE: To clarify the transport and inhibition characteristics involved in verapamil transport across the inner blood-retinal barrier (inner BRB). METHODS: The transport of [(3)H]verapamil across the inner BRB was investigated using retinal uptake index and integration plot analyses in rats. The detailed transport characteristics were studied using TR-iBRB2 cells, a conditionally immortalized rat retinal capillary endothelial cell line that is an in vitro model of the inner BRB. RESULTS: The apparent influx permeability clearance of [(3)H]verapamil was 614 μL/(min·g retina), which is 4.7-fold greater than that of brain. The retinal uptake of [(3)H]verapamil was slightly increased by 3 mM verapamil and 10 mM qunidine and inhibited by 40 mM pyrilamine, supporting the carrier-mediated efflux and influx transport of verapamil across the inner BRB. TR-iBRB2 cells exhibited a concentration-dependent uptake of [(3)H]verapamil with a K (m) of 61.9 μM, and the uptake was inhibited by several cations, such as pyrilamine, exhibiting a different profile from the identified transporters. These transport properties suggest that verapamil transport at the inner BRB takes place via a novel organic cation transporter. CONCLUSIONS: Our findings suggest that a novel organic cation transporter is involved in verapamil transport from the blood to the retina across the inner BRB.
    [Abstract] [Full Text] [Related] [New Search]